Entities & Trading Partners Defined Under The DSCSA “The Food and Drug Administration (FDA or the Agency) is issuing this guidance to assist industry and State and local governments in understanding how to categorize the entities in the drug supply chain in accordance with the Drug Supply Chain Security Act (DSCSA). DSCSA establishes product tracing […]
Tag: DSCSA
GS1 US Workshop Series Offers Pharmaceutical Industry Professionals DSCSA Implementation Assistance | Healthcare Packaging
“Specifically, how to mark pharmaceutical products with a National Drug Code (NDC), serial number, lot number, and expiration date in both machine-readable and human-readable format will be covered, as will the use of GS1 identifiers, application identifiers, and data carriers.” Read the full article (Source): GS1 US Workshop Series Offers Pharmaceutical Industry Professionals DSCSA Implementation […]
How drugs intended for patients ended up in the hands of illegal users: ‘No one was doing their job’ – The Washington Post
“For 10 years, the government waged a behind-the-scenes war against pharmaceutical companies that hardly anyone knows: wholesale distributors of prescription narcotics that ship drugs from manufacturers to consumers.” Read the full article: Source: How drugs intended for patients ended up in the hands of illegal users: ‘No one was doing their job’ – The Washington […]
The Forwarder Awakens: Amazon receives NVOCC | Air Cargo World
“Many in the industry had speculated that Amazon was making the investments in logistics networking merely to avoid future delays in shipping goods during peak season, as the e-tailer had experienced before with integrator such as FedEx and UPS. But the NVOCC license suggests that Amazon is interested in becoming a permanent player in the […]
FDA Releases First Wholesaler and 3PL Facility Licensure Data to the Public | The National Law Review
“Users either can query the database when searching for a particular company here or download the entire data set as an Excel file from this page. Although technically the law only requires a public wholesale distributor database, FDA determined that making the 3PL information public as well served the law’s goals, and it stated in a December […]
3PL Acquisitions Expected to Increase – Pharmaceutical Processing
“They attributed the increase to growing pressure to expand services, increase geographic footprints and drive scale in specific markets. Consolidating firms will need to weather significant industry restructuring and navigate brand confusion in some markets, the report said. This year, meanwhile, respondents expected those large 2014 deals to lead to defensive acquisitions by other firms.” […]